v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2024 $ 1 $ 143,787 $ (135,857) $ 7,931
Balance at beginning of period (in shares) at Dec. 31, 2024 785,194      
Increase (Decrease) in Stockholders' Equity        
Issuance of common stock for vested restricted stock units, net of shares withheld for withholding taxes   (12)   (12)
Issuance of common stock for vested restricted stock units, net of shares withheld for withholding taxes (in shares) 1,612      
Stock-based compensation   132   132
Net loss     (3,671) (3,671)
Balance at end of period at Mar. 31, 2025 $ 1 143,907 (139,528) 4,380
Balance at end of period (in shares) at Mar. 31, 2025 786,806      
Balance at beginning of period at Dec. 31, 2024 $ 1 143,787 (135,857) 7,931
Balance at beginning of period (in shares) at Dec. 31, 2024 785,194      
Increase (Decrease) in Stockholders' Equity        
Net loss       (7,666)
Balance at end of period at Jun. 30, 2025 $ 2 153,145 (143,523) 9,624
Balance at end of period (in shares) at Jun. 30, 2025 2,199,481      
Balance at beginning of period at Mar. 31, 2025 $ 1 143,907 (139,528) 4,380
Balance at beginning of period (in shares) at Mar. 31, 2025 786,806      
Increase (Decrease) in Stockholders' Equity        
Issuance of common stock and pre-funded warrants, net of issuance costs $ 1 9,121   9,122
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares) 861,759      
Issuance of common stock for exercise of warrants   6   6
Issuance of common stock for exercise of warrants (in shares) 548,651      
Issuance of common stock for vested restricted stock units, net of shares withheld for withholding taxes (in shares) 2,265      
Stock-based compensation   111   111
Net loss     (3,995) (3,995)
Balance at end of period at Jun. 30, 2025 $ 2 153,145 (143,523) 9,624
Balance at end of period (in shares) at Jun. 30, 2025 2,199,481      
Balance at beginning of period at Dec. 31, 2025 $ 2 154,161 (148,830) $ 5,333
Balance at beginning of period (in shares) at Dec. 31, 2025 2,308,294     2,308,294
Increase (Decrease) in Stockholders' Equity        
Issuance of common stock and warrants in connection with an underwritten public offering, net of issuance costs $ 1 7,146   $ 7,147
Issuance of common stock and warrants in connection with an underwritten public offering, net of issuance costs (in shares) 1,006,870      
Issuance of common stock under an at the market offering agreement, net of issuance costs   314   314
Issuance of common stock under an at the market offering agreement, net of issuance costs (in shares) 216,625      
Issuance of common stock for exercise of warrants $ 2     2
Issuance of common stock for exercise of warrants (in shares) 1,630,964      
Issuance of common stock for vested restricted stock units, net of shares withheld for withholding taxes (in shares) 1,617      
Stock-based compensation   100   100
Net loss     (3,823) (3,823)
Balance at end of period at Mar. 31, 2026 $ 5 161,721 (152,653) 9,073
Balance at end of period (in shares) at Mar. 31, 2026 5,164,370      
Balance at beginning of period at Dec. 31, 2025 $ 2 154,161 (148,830) $ 5,333
Balance at beginning of period (in shares) at Dec. 31, 2025 2,308,294     2,308,294
Increase (Decrease) in Stockholders' Equity        
Net loss       $ (9,139)
Balance at end of period at Jun. 30, 2026 $ 7 164,784 (157,969) $ 6,822
Balance at end of period (in shares) at Jun. 30, 2026 6,575,656     6,575,656
Balance at beginning of period at Mar. 31, 2026 $ 5 161,721 (152,653) $ 9,073
Balance at beginning of period (in shares) at Mar. 31, 2026 5,164,370      
Increase (Decrease) in Stockholders' Equity        
Issuance of common stock under an at the market offering agreement, net of issuance costs   383   383
Issuance of common stock under an at the market offering agreement, net of issuance costs (in shares) 206,294      
Underwritten public offering issuance costs   (10)   (10)
Issuance of common stock for exercise of warrants $ 2 2,416   2,418
Issuance of common stock for exercise of warrants (in shares) 1,147,318      
Issuance of common stock for professional services   144   144
Issuance of common stock for professional services (in shares) 50,000      
Issuance of common stock for vested restricted stock units (in shares) 7,674      
Stock-based compensation   130   130
Net loss     (5,316) (5,316)
Balance at end of period at Jun. 30, 2026 $ 7 $ 164,784 $ (157,969) $ 6,822
Balance at end of period (in shares) at Jun. 30, 2026 6,575,656     6,575,656